1.,Changes of the name of the biocidal product where there is no risk of confusion with the names of other biocidal products.,
2.,Addition of a name for the biocidal product where there is no risk of confusion with the names of other biocidal products.,

3.,Transfer of the authorisation to a new holder established in the United Kingdom .,
4.,Change in the name or address of the authorisation holder, which remains in the United Kingdom .,

5.,Addition of a manufacturer of the active substance or change in the manufacturer’s identity or in manufacturing location or process, where the technical equivalence between the substances from the two manufacturers, manufacturing locations and processes has been established by the competent authority in accordance with Article 54 of Regulation (EU) No 528/2012, and the manufacturer or importer is listed in accordance with Article 95(2) of Regulation (EU) No 528/2012.,

6.,Authorisation as a biocidal product family of a number of authorised products falling within the specifications of a frame-formulation established in accordance with Directive 98/8/EC in accordance with the same terms and conditions.,
OJ L 353, 31.12.2008, p. 1 .,

1.,Change in other administrative details of the authorisation holder than the name and address.,

2.,Change in the name, the administrative details or the formulating location of the biocidal product formulator, where the biocidal product composition and the formulating process remain unchanged.,
3.,Deletion of a formulating location or a formulator of the biocidal product,
4.,Addition of a formulator of the biocidal product, where the biocidal product composition and the formulating process remain unchanged.,

5.,Change in the name or the administrative details of a manufacturer of the active substance, where the manufacturing location and process remain unchanged and the manufacturer remains listed in accordance with Article 95(2) of Regulation (EU) No 528/2012,
6.,Deletion of a manufacturer or a manufacturing location of the active substance,

7.,More precise instructions for use, where only wording but not content of instructions are changed.,
8.,Removal of a particular claim, such as a specific target organism or a specific use.,
9.,Removal of a category of users.,
10.,Addition, replacement or modification of a measuring or administration device not relevant for the risk assessment and not regarded as a risk mitigation measure.,

11.,Change to the classification and labelling, where the change is limited to what is necessary to comply with newly applicable requirements of Regulation (EC) No 1272/2008 of the European Parliament and of the Council .,

1.,Increase or reduction, addition, deletion or replacement of a non-active substance intentionally incorporated in the product, where: The added or increased non active-substance is not a substance of concern. The deletion or reduction of the non-active substance does not lead to an increase of an active substance or a substance of concern. The physical-chemical properties and the shelf-life of the product are expected to remain the same. The risk and efficacy profile are expected to remain the same. A new quantitative risk assessment is not expected to be necessary,
2.,Increase, reduction, addition or deletion, or replacement of a non-active substance intentionally incorporated in a biocidal product family outside the authorised range, where: The added or increased non-active substance is not a substance of concern. The deletion or reduction of the non-active substance does not lead to an increase of an active substance or a substance of concern. The physical-chemical properties and the shelf-life of the products of the biocidal product family remain the same. The risk and efficacy profile are expected to remain the same. A new quantitative risk assessment is not expected to be necessary.,

3.,Changed instructions for use, where the changes do not adversely affect the exposure,
4.,Addition, replacement or modification of a measuring or administration device relevant for the risk assessment and regarded as a risk mitigation measure, where: The new device accurately delivers the required dose for the biocidal product concerned in line with the approved conditions of use. The new device is compatible with the biocidal product. The change is not expected to adversely affect the exposure.,

5.,Change in the shelf-life.,
6.,Change in the conditions of storage,

7.,Change in the pack size range, where: New range is consistent with the dose rate and instructions for use as approved in the summary of the biocidal product characteristics. No change of user category. The same risk-mitigation measures apply.,